These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 24846128)

  • 21. The protective effect of the EP2 receptor on TGF-β1 induced podocyte injury via the PI3K / Akt signaling pathway.
    Liu J; Zhang YD; Chen XL; Zhu XL; Chen X; Wu JH; Guo NF
    PLoS One; 2018; 13(5):e0197158. PubMed ID: 29746568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes.
    Xavier S; Niranjan T; Krick S; Zhang T; Ju W; Shaw AS; Schiffer M; Böttinger EP
    J Am Soc Nephrol; 2009 Oct; 20(10):2127-37. PubMed ID: 19679673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD2AP/CIN85 balance determines receptor tyrosine kinase signaling response in podocytes.
    Tossidou I; Kardinal C; Peters I; Kriz W; Shaw A; Dikic I; Tkachuk S; Dumler I; Haller H; Schiffer M
    J Biol Chem; 2007 Mar; 282(10):7457-64. PubMed ID: 17213204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship among nephrin, podocin, CD2AP, and alpha-actinin might not be a true 'interaction' in podocyte.
    Fan Q; Xing Y; Ding J; Guan N; Zhang J
    Kidney Int; 2006 Apr; 69(7):1207-15. PubMed ID: 16501493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with irbesatan may improve slit diaphragm alterations in rats with adriamycin-induced nephropathy.
    Wang N; Wei RB; Li P; Li QP; Yang X; Yang Y; Huang MJ; Wang R; Yin Z; Lv Y; Chen XM
    J Renin Angiotensin Aldosterone Syst; 2016; 17(2):1470320316646884. PubMed ID: 27169889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival.
    Yaddanapudi S; Altintas MM; Kistler AD; Fernandez I; Möller CC; Wei C; Peev V; Flesche JB; Forst AL; Li J; Patrakka J; Xiao Z; Grahammer F; Schiffer M; Lohmüller T; Reinheckel T; Gu C; Huber TB; Ju W; Bitzer M; Rastaldi MP; Ruiz P; Tryggvason K; Shaw AS; Faul C; Sever S; Reiser J
    J Clin Invest; 2011 Oct; 121(10):3965-80. PubMed ID: 21911934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
    Trohatou O; Tsilibary EF; Charonis A; Iatrou C; Drossopoulou G
    J Cell Mol Med; 2017 Oct; 21(10):2599-2609. PubMed ID: 28664547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interplay between the Notch and PI3K/Akt pathways in high glucose-induced podocyte apoptosis.
    Wang XM; Yao M; Liu SX; Hao J; Liu QJ; Gao F
    Am J Physiol Renal Physiol; 2014 Jan; 306(2):F205-13. PubMed ID: 24226527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling.
    Huber TB; Hartleben B; Kim J; Schmidts M; Schermer B; Keil A; Egger L; Lecha RL; Borner C; Pavenstädt H; Shaw AS; Walz G; Benzing T
    Mol Cell Biol; 2003 Jul; 23(14):4917-28. PubMed ID: 12832477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury.
    Mitu GM; Wang S; Hirschberg R
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1641-8. PubMed ID: 17804487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo.
    Menne J; Meier M; Park JK; Boehne M; Kirsch T; Lindschau C; Ociepka R; Leitges M; Rinta-Valkama J; Holthofer H; Haller H
    Kidney Int; 2006 Oct; 70(8):1456-62. PubMed ID: 16955103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products.
    McRobert EA; Bach LA
    Nephrology (Carlton); 2016 Jan; 21(1):13-20. PubMed ID: 26032400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
    Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
    Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ameliorating effects of L-carnitine on diabetic podocyte injury.
    Fan JP; Kim D; Kawachi H; Ha TS; Han GD
    J Med Food; 2010 Dec; 13(6):1324-30. PubMed ID: 20946020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli.
    Miyauchi N; Saito A; Karasawa T; Harita Y; Suzuki K; Koike H; Han GD; Shimizu F; Kawachi H
    J Am Soc Nephrol; 2006 Oct; 17(10):2748-59. PubMed ID: 16943307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M; Liu M; Xiong M; Gong J; Tan X
    J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions.
    Paeng J; Chang JH; Lee SH; Nam BY; Kang HY; Kim S; Oh HJ; Park JT; Han SH; Yoo TH; Kang SW
    Apoptosis; 2014 Dec; 19(12):1678-90. PubMed ID: 25284613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High glucose reduces expression of podocin in cultured human podocytes by stimulating TRPC6.
    Lu XY; Liu BC; Cao YZ; Song C; Su H; Chen G; Klein JD; Zhang HX; Wang LH; Ma HP
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1605-F1611. PubMed ID: 31566428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of CD2AP disrupts Glut4 trafficking and attenuates glucose uptake in podocytes.
    Tolvanen TA; Dash SN; Polianskyte-Prause Z; Dumont V; Lehtonen S
    J Cell Sci; 2015 Dec; 128(24):4588-600. PubMed ID: 26546360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy.
    Benigni A; Gagliardini E; Tomasoni S; Abbate M; Ruggenenti P; Kalluri R; Remuzzi G
    Kidney Int; 2004 Jun; 65(6):2193-200. PubMed ID: 15149332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.